Developmental arrest of T cells in Rpl22-deficient mice is dependent upon multiple p53 effectors

Journal of Immunology

Volumn 187, Issue 2, 2011, Pages 664-675

  Stadanlick, Jason E ^a   Zhang, Zhiqiang ^a   Lee, Sang Yun ^a   Hemann, Mike ^b   Biery, Matthew ^c   Carleton, Michael O ^c   Zambetti, Gerard P ^d   Anderson, Stephen J ^e   Oravecz, Tamas ^a,e   Wiest, David L ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c ROSETTA INPHARMATICS   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e LEXICON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROTEIN BAX; PROTEIN P53; PUMA PROTEIN; RIBOSOMAL PROTEIN L22; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; GAIN OF FUNCTION MUTATION; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; DOWN-REGULATION; GENE TARGETING; GROWTH INHIBITORS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RIBOSOMAL PROTEINS; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 79960526901     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100029     Document Type: Article

References (57)

1. Hoffman, E. S., L. Passoni, T. Crompton, T. M. Leu, D. G. Schatz, A. Koff, M. J. Owen, and A. C. Hayday. 1996. Productive T-cell receptor beta-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo. Genes Dev. 10: 948-962.
2. Kruisbeek, A. M., M. C. Haks, M. Carleton, A. M. Michie, J. C. Zúñiga-Pflücker, and D. L. Wiest. 2000. Branching out to gain control: how the pre-TCR is linked to multiple functions. Immunol. Today 21: 637-644.
3. von Boehmer, H. 2005. Unique features of the pre-T-cell receptor alpha-chain: not just a surrogate. Nat. Rev. Immunol. 5: 571-577.
4. Michie, A. M., and J. C. Zúñiga-Pflücker. 2002. Regulation of thymocyte differentiation: pre-TCR signals and beta-selection. Semin. Immunol. 14: 311-323.
5. Aifantis, I., M. Mandal, K. Sawai, A. Ferrando, and T. Vilimas. 2006. Regulation of T-cell progenitor survival and cell-cycle entry by the pre-T-cell receptor. Immunol. Rev. 209: 159-169.
6. Koltsova, E. K., M. Ciofani, R. Benezra, T. Miyazaki, N. Clipstone, J. C. Zúñiga-Pflücker, and D. L. Wiest. 2007. Early growth response 1 and NF-ATc1 act in concert to promote thymocyte development beyond the beta-selection checkpoint. J. Immunol. 179: 4694-4703.
7. Anderson, S. J., J. P. Lauritsen, M. G. Hartman, A. M. Foushee, J. M. Lefebvre, S. A. Shinton, B. Gerhardt, R. R. Hardy, T. Oravecz, and D. L. Wiest. 2007. Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint. Immunity 26: 759-772.
8. Lavergne, J. P., A. Marzouki, J. P. Reboud, and A. M. Reboud. 1988. Reconstitution of the active rat liver 60 S ribosomal subunit from different preparations of core particles and split proteins. FEBS Lett. 236: 345-351.
9. Lavergne, J. P., F. Conquet, J. P. Reboud, and A. M. Reboud. 1987. Role of acidic phosphoproteins in the partial reconstitution of the active 60 S ribosomal subunit. FEBS Lett. 216: 83-88.
10. Draptchinskaia, N., P. Gustavsson, B. Andersson, M. Pettersson, T. N. Willig, I. Dianzani, S. Ball, G. Tchernia, J. Klar, H. Matsson, et al. 1999. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat. Genet. 21: 169-175.
11. Ruggero, D., and P. P. Pandolfi. 2003. Does the ribosome translate cancer? Nat. Rev. Cancer 3: 179-192.
12. Wool, I. G. 1996. Extraribosomal functions of ribosomal proteins. Trends Biochem. Sci. 21: 164-165.
13. Fumagalli, S., A. Di Cara, A. Neb-Gulati, F. Natt, S. Schwemberger, J. Hall, G. F. Babcock, R. Bernardi, P. P. Pandolfi, and G. Thomas. 2009. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat. Cell Biol. 11: 501-508.
14. Lohrum, M. A., R. L. Ludwig, M. H. Kubbutat, M. Hanlon, and K. H. Vousden. 2003. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3: 577-587.
15. Dai, M. S., and H. Lu. 2004. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem. 279: 44475-44482.
16. Ofir-Rosenfeld, Y., K. Boggs, D. Michael, M. B. Kastan, and M. Oren. 2008. Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol. Cell 32: 180-189.
17. Takagi, M., M. J. Absalon, K. G. McLure, and M. B. Kastan. 2005. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123: 49-63.
18. Willis, S. N., and J. M. Adams. 2005. Life in the balance: how BH3-only proteins induce apoptosis. Curr. Opin. Cell Biol. 17: 617-625.
19. Bouillet, P., D. Metcalf, D. C. Huang, D. M. Tarlinton, T. W. Kay, F. Köntgen, J. M. Adams, and A. Strasser. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286: 1735-1738. (Pubitemid 129515880)
20. Erlacher, M., E. M. Michalak, P. N. Kelly, V. Labi, H. Niederegger, L. Coultas, J. M. Adams, A. Strasser, and A. Villunger. 2005. BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 106: 4131-4138. (Pubitemid 41775918)
21. Jeffers, J. R., E. Parganas, Y. Lee, C. Yang, J. Wang, J. Brennan, K. H. MacLean, J. Han, T. Chittenden, J. N. Ihle, et al. 2003. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4: 321-328. (Pubitemid 37329796)
22. Villunger, A., C. Scott, P. Bouillet, and A. Strasser. 2003. Essential role for the BH3-only protein Bim but redundant roles for Bax, Bcl-2, and Bcl-w in the control of granulocyte survival. Blood 101: 2393-2400. (Pubitemid 36302087)
23. Shibue, T., K. Takeda, E. Oda, H. Tanaka, H. Murasawa, A. Takaoka, Y. Morishita, S. Akira, T. Taniguchi, and N. Tanaka. 2003. Integral role of Noxa in p53-mediated apoptotic response. Genes Dev. 17: 2233-2238. (Pubitemid 37128638)
24. Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
25. Di Micco, R., A. Cicalese, M. Fumagalli, M. Dobreva, A. Verrecchia, P. G. Pelicci, and F. di Fagagna. 2008. DNA damage response activation in mouse embryonic fibroblasts undergoing replicative senescence and following spontaneous immortalization. Cell Cycle 7: 3601-3606.
26. el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
27. Raver-Shapira, N., E. Marciano, E. Meiri, Y. Spector, N. Rosenfeld, N. Moskovits, Z. Bentwich, and M. Oren. 2007. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26: 731-743. (Pubitemid 46856247)
28. Shibue, T., S. Suzuki, H. Okamoto, H. Yoshida, Y. Ohba, A. Takaoka, and T. Taniguchi. 2006. Differential contribution of Puma and Noxa in dual regulation of p53-mediated apoptotic pathways. EMBO J. 25: 4952-4962. (Pubitemid 44607039)
29. Shinkai, Y., G. Rathbun, K.-P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, and F. W. Alt. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
30. Fehling, H. J., A. Krotkova, C. Saint-Ruf, and H. von Boehmer. 1995. Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells. [published erratum appears in Nature 1995 Nov 23;378 (6555):419] Nature 375: 795-798.
31. Jacks, T., L. Remington, B. O. Williams, E. M. Schmitt, S. Halachmi, R. T. Bronson, and R. A. Weinberg. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1-7.
32. Dickins, R. A., M. T. Hemann, J. T. Zilfou, D. R. Simpson, I. Ibarra, G. J. Hannon, and S. W. Lowe. 2005. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat. Genet. 37: 1289-1295.
33. Fehling, H. J., B. M. Iritani, A. Krotkova, K. A. Forbush, C. Laplace, R. M. Perlmutter, and H. von Boehmer. 1997. Restoration of thymopoiesis in pT alpha-/- mice by anti-CD3epsilon antibody treatment or with transgenes encoding activated Lck or tailless pT alpha. Immunity 6: 703-714. (Pubitemid 27305733)
34. Surh, C. D., and J. Sprent. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372: 100-103. (Pubitemid 24339491)
35. -/- mice in the absence of TCR beta chain expression. Int. Immunol. 6: 995-1001.
36. Azzam, H. S., A. Grinberg, K. Lui, H. Shen, E. W. Shores, and P. E. Love. 1998. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188: 2301-2311.
37. He, L., X. He, L. P. Lim, E. de Stanchina, Z. Xuan, Y. Liang, W. Xue, L. Zender, J. Magnus, D. Ridzon, et al. 2007. A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134. (Pubitemid 47014436)
38. Tarasov, V., P. Jung, B. Verdoodt, D. Lodygin, A. Epanchintsev, A. Menssen, G. Meister, and H. Hermeking. 2007. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6: 1586-1593. (Pubitemid 47327945)
39. Schmitt, T. M., and J. C. Zúñiga-Pflücker. 2002. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17: 749-756.
40. Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
41. Mandal, M., K. M. Crusio, F. Meng, S. Liu, M. Kinsella, M. R. Clark, O. Takeuchi, and I. Aifantis. 2008. Regulation of lymphocyte progenitor survival by the proapoptotic activities of Bim and Bid. Proc. Natl. Acad. Sci. USA 105: 20840-20845.
42. Ren, D., H. C. Tu, H. Kim, G. X. Wang, G. R. Bean, O. Takeuchi, J. R. Jeffers, G. P. Zambetti, J. J. Hsieh, and E. H. Cheng. 2010. BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science 330: 1390-1393.
43. Michalak, E., A. Villunger, M. Erlacher, and A. Strasser. 2005. Death squads enlisted by the tumour suppressor p53. Biochem. Biophys. Res. Commun. 331: 786-798.
44. Hutcheson, J., J. C. Scatizzi, A. M. Siddiqui, G. K. Haines, III, T. Wu, Q. Z. Li, L. S. Davis, C. Mohan, and H. Perlman. 2008. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28: 206-217. (Pubitemid 351215233)
45. Khaled, A. R., W. Q. Li, J. Huang, T. J. Fry, A. S. Khaled, C. L. Mackall, K. Muegge, H. A. Young, and S. K. Durum. 2002. Bax deficiency partially corrects interleukin-7 receptor alpha deficiency. Immunity 17: 561-573.
46. Strasser, A. 2005. The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 5: 189-200.
47. Komarova, E. A., K. Christov, A. I. Faerman, and A. V. Gudkov. 2000. Different impact of p53 and p21 on the radiation response of mouse tissues. Oncogene 19: 3791-3798.
48. Komarova, E. A., R. V. Kondratov, K. Wang, K. Christov, T. V. Golovkina, J. R. Goldblum, and A. V. Gudkov. 2004. Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastrointestinal syndrome in mice. Oncogene 23: 3265-3271.
49. Gartel, A. L., and S. K. Radhakrishnan. 2005. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 65: 3980-3985.
50. Villeneuve, N. F., Z. Sun, W. Chen, and D. D. Zhang. 2009. Nrf2 and p21 regulate the fine balance between life and death by controlling ROS levels. Cell Cycle 8: 3255-3256.
51. Chen, W., Z. Sun, X. J. Wang, T. Jiang, Z. Huang, D. Fang, and D. D. Zhang. 2009. Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol. Cell 34: 663-673.
52. Sohn, D., F. Essmann, K. Schulze-Osthoff, and R. U. Jänicke. 2006. p21 blocks irradiation-induced apoptosis downstream of mitochondria by inhibition of cyclin-dependent kinase-mediated caspase-9 activation. Cancer Res. 66: 11254-11262.
53. Prinz, I., A. Sansoni, A. Kissenpfennig, L. Ardouin, M. Malissen, and B. Malissen. 2006. Visualization of the earliest steps of gammadelta T cell development in the adult thymus. Nat. Immunol. 7: 995-1003.
54. Taghon, T., M. A. Yui, R. Pant, R. A. Diamond, and E. V. Rothenberg. 2006. Developmental and molecular characterization of emerging beta- and gammadelta-selected pre-T cells in the adult mouse thymus. Immunity 24: 53-64.
55. Beverly, L. J., D. W. Felsher, and A. J. Capobianco. 2005. Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression. Cancer Res. 65: 7159-7168.
56. Chan, S. M., A. P. Weng, R. Tibshirani, J. C. Aster, and P. J. Utz. 2007. Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood 110: 278-286.
57. Ciofani, M., G. C. Knowles, D. L. Wiest, H. von Boehmer, and J. C. Zúñiga-Pflücker. 2006. Stage-specific and differential notch dependency at the alphabeta and gammadelta T lineage bifurcation. Immunity 25: 105-116.